MedCrypt
Bob Lyle is an accomplished executive with extensive experience in revenue generation, business development, and cybersecurity within the technology sector. Currently serving as Chief Revenue Officer at Medcrypt, Bob leads sales and marketing initiatives for advanced encryption and monitoring services targeting medical device manufacturers. As a Limited Partner at Stage 2 Capital, Bob supports early-stage B2B software companies, leveraging a vast network for coaching and strategic growth. Bob holds leadership roles in various organizations, including Deputy Chair of the Device Security Group at GSMA and Strategic Advisor positions at companies like Freebit AS and Cybeats. Bob's entrepreneurial background includes founding Valona Labs, which provided cybersecurity solutions and achieved a successful exit within 18 months. Educational credentials include an MBA from Arizona State University, an Executive Certificate from MIT Sloan School of Management, and degrees in Electrical Engineering from Purdue University.
This person is not in any teams
This person is not in any offices
MedCrypt
MedCrypt is a medical device company that provides data security as a service to medical device OEMs. From medical imaging device to implantable devices like pacemakers, MedCrypt ensures that devices act only on instructions from trusted sources. It brings security features to medical devices, from pacemakers to surgical robots, in a few lines ofcode. The company enables engineers to implement these security features properly as quickly as possible, allowing them to get back to designing life-changing clinical features.MedCrypt was founded in 2016 and is headquartered in Encinitas, California, United States.